Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics (Q35745999)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2004
edit
Language Label Description Also known as
English
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics
scientific article published on February 2004

    Statements

    Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics (English)
    Carlos A Vieira
    Avinash Agarwal
    Benita K Book
    Richard A Sidner
    Christopher M Bearden
    Howard M Gebel
    Anthony L Roggero
    Timothy Taber
    Michael A Kraus
    Mark D Pescovitz
    1 February 2004
    542-548

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit